The failure to improve the five-year survival rate of cancer patients, from one in three in the 1960s to one in two in the 1970s, stimulated awareness of the importance of primary prevention of cancer. Korean investigators carried out extensive long-term anticarcinogenicity experiments with 2000 newborn mice to investigate whether Panax ginseng C.A. Meyer inhibited carcinogenesis induced by several chemical carcinogens in 1978. There was a 22% decrease (p <0.05) in the incidence of urethane induced lung adenoma by the combined use of red ginseng extract. In the group sacrificed at 56 weeks after the treatment with aflatoxin B1, the incidence of hepatoma significantly decreased to 75% by the addition of red ginseng extract (p <0.05). The result showed that natural products can provide hope for human cancer prevention. By the newly established '9 week mediumterm anticarcinogenicity test model of lung tumors in mice' (Yun' s model), we confirmed significant anticarcinogenic effects of powders and extracts of the 6-yr-old dried fresh ginseng, 5-and 6-yr old white ginsengs, and 4-, 5-, and 6-yr old red ginseng. We also demonstrated that the anticarcinogencity of ginseng was more prominent in aged or heat treated extracts of ginseng and red ginseng made by steaming. To investigate the active components for cancer prevention, several fractions of 6-yr old fresh ginseng and red ginseng, four semi-synthetic ginsenoside Rh1, Rh2, Rg3 and Rg5, major saponin components in red ginseng, were prepared. Among the ginsenosides, Rg3 and Rg5 showed statistically significant reduction of lung tumor incidence and Rh2 had a tendency of decreasing the incidence. Ginsenoside Rg3, Rg5 and Rh2 were found to be active anticarcinogenic compounds. Rg3, Rg5 and Rh2 are active components in red ginseng, and they prevent cancer either singularly or synergistically.
INTRODUCTION
Despite of great advances in early diagnosis and logical discovery of chemotherapy for cancer and of substantial advances in molecular oncology, the cure rate of most cancers remain still low. Primary cancer prevention, particularly chemoprevention, could become an increasingly useful strategy in the fight against cancer (1) . Fifty years have passed since the first chemotherapeutic alkylating agent was developed, and more than a hundred clinical chemotherapeutic regimens have been developed (2, 3) . Nevertheless, the total number of new cancer patients worldwide in 1985 was estimated to be 7.62 million (4) . The failure to improve the 5-yr observed survival from 1 in 3 in the 1960s to 1 in 2 in the 1970s stimulated awareness of the importance of primary prevention in cancer; chemoprevention (5) . Since 1977, researchers in Korea have been trying to discover non-toxic cancer chemopreventive agents from natural food products, including ginseng (6) .
LONG-TERM ANTICARCINOGENICITY EXPERIMENT
It is hypothesized that the life-prolongation effect of ginseng described by Shennong (7) may be due to ginseng' s efficacy in preventing development of cancers. Therefore, an investigation was carried out in 1978 to evaluate the effects of ginseng on the inhibition or prevention of carcinogenesis induced by various chemical carcinogens. Red ginseng ( Fig.  1 ) extract (1 mg/mL of drinking water) was administered orally to the weaned mice, and chemical carcinogens, 9, 10-demethyl-1, 2-benzanthracene (DMBA, 30 g), urethane (1 mg), N-2 fluorenylacetamide (FAA, 100 g×5), aflatoxin B1 (8 g), or Hansando tobacco smoke condensates (320 g) were also injected into the subscapular region of ICR mice within 24 hr after birth. Controls were comprised of three groups of ICR newborn mice: normal (100), ginseng (200), and vehicle (316). The ten experimental groups were (88) , aflatoxin B1 (50) , aflatoxin B1 combined with ginseng (47) ( Table 1 ). In the N-methyl-N′ -nitro-N-nitrosoguanidine (MNNG) group, MNNG (3 mg) was injected subcutaneously into the backs of Wistar rats once a week for 10 weeks (6, 8) . The mice and rats were autopsied immediately after sacrifice. All major organs were grossly examined and weighed, and histopathological examinations were also made. In the group sacrificed at 48 weeks after the treatment with DMBA (DMBA combined with ginseng), the incidence of diffuse infiltration of pulmonary adenoma decreased by 61% (p<0.01), and the average lung weight of male mice decreased by 21% (p<0.05). In the group sacrificed at 28 weeks after the treatment with urethane, there was 22% decrease (p< 0.05) in the incidence of lung adenoma by the combined treatment with ginseng. In the group sacrificed at 56 weeks after treatment with aflatoxin B1, there was decrease in the incidence of lung adenoma (29%) and hepatoma (75%) (p< 0.05) by the combined treatment with ginseng (Table 2 ). In the groups sacrificed at 68 weeks after the treatment with FAA or 48 weeks of tobacco smoke condensate treatment, statistically no significant decrease was observed. In the group sacrificed at 27 weeks after treatment with MNNG, ginseng extract had no effect on the incidence of MNNG-induced sarcoma by the combined treatment with ginseng. These findings indicated that prolonged administration of red ginseng extract inhibited the incidence and also the proliferation of tumors induced by DMBA, urethane, or aflatoxin B1 (6, 8) , providing the hope for human cancer prevention by natural products in human.
ESTABLISHMENT OF 9 WEEK MEDIUM-TERM ANTICARCINOGENICITY TEST MODEL (YUN' S MODEL)
Soon after obtaining results of long-term experiments, we realized that it was necessary to develop a medium-term (9) . A/J, C57BL/6J, C57BR/cdJ and N:GP(S) strains of newborn mice younger than 24 hr old were injected subcutaneously with 0.5 mg or 1 mg of BP and all mice were sacrificed at the 9th week after birth. Lungs were excised and fixed in Tellyesniczky' s solution (100 mL of 70% ethanol, 3 mL of formalin, 5 mL of glacial acetic acid), and the number of the adenoma were than counted by the naked eyes (Fig. 2) . After counting, the lungs were embedded in paraffin, cut and then stained with hematoxylineosin. To obtain an index of tumor incidence, the percentage of tumor bearing mice per total number of mice in each group was calculated. Tumor multiplicity was defined as the average number of tumors per mouse obtained, by dividing the total number of tumors by the total number of mice per group including nontumor-bearing animals. Statistical comparison was then made using the Chi-square test for tumor incidence and Student' s t-test for multiplicity. Lung adenoma incidence was 46.8% and 54.4% in N:GP(S) mice treated with 0.5 mg and 1 mg of BP, respectively. Corresponding values of A/J mice were 86.7% and 88.3%, those of C57BL/6J mice were 1.3% and 0%, and those of C57BR/ cdJ were 0%. The dose response effect of BP in A/J and N:GP(S) mice were also examined: A single injection of 40 g of BP, which was the lowest dose in this experiment, showed 71.0% incidence of lung adenoma in A/J mice, which might be too high incidence for evaluating the anticarcinogenicity of unknown compounds. However, the dose showing a 50% tumor incidence in N:GP(S) mice was found to be 0.5 mg of BP (49.4%) (9) (10) (11) (12) . In 1983, we established a 9 week medium-term anticarcinogenicity model, termed Yun' s model, based on the incidence of N:GP(S) mouse pulmonary adenomas induced by benzo(a) pyrene.
MATERIALS AND METHODS OF YUN' S MODEL
N:GP(S) newborn mice less than 24 hr old were subcutaneously injected once in the scapular region with 0.02 mL of benzo(a)pyrene (0.5 mg suspension of BP in aqueous gelatin). After weaning, test materials were administered for 6 weeks through drinking water or diets. All mice were sacrificed at the 9th week after birth. The procedures to score the index of lung tumor incidence were the same as those described under "Establishment of 9 week mediumterm anticarcinogenicity test model (Yun' s model)" (9) (10) (11) (12) .
EVALUATION OF YUN' S MODEL
Ascorbic acid, -carotene, red ginseng extract (6 yr old), carrot, soybean lecithin, spinach, Sesamum indicum, Ganoderma lucidum, caffeine, capsaicin (13) (14) (15) , fresh ginseng (4 yr old), biochanin A (16) and 2-allylthiopyrazine (17, 18) were evaluated as anticarcinogenic agents, using the above 9 week medium-term test model. Surprisingly, the authors failed to observe any anticarcinogenic effect of -carotene, fresh ginseng, carrot, Sesamum indicum, spinach, however, ascorbic acid, red ginseng extract, soybean lecithin, Ganoderma lucidum, caffeine, capsaicin and 2-allylthiopyrazine showed positive effects (10) (11) (12) 19) . This result was withheld for publication for 5 yr due to the unexplainability of the data (9) . Soon after, the preliminary reports of the Physician' s Health Study in U.S.A. appeared to indicate negative results with -carotene (20) . Similar results of lack of efficacy were also observed in an ATBC trial using 29,133 randomly selected male smokers (21), a CARET trial studying more than 18,000 people at high risk of lung cancer (22, 23) , and a Physicians'Health Study which enrolled 22,071 American physicians (24) . At the recommendation of the Chemoprevention Branch, Division of Cancer Chemoprevention and Control, US National Cancer Institute (25, 26) , researchers in Korea tested the effect of red ginseng extract on azoxymethane (AOM)-induced colon cancer and N-butyl-N-(4-hydroxybutyl)-nitrosamine (OH-BBN)-induced bladder cancer, and the result were negative (unpublished). Moreover, 13-cis retinoic acid was also without benefit in the 9-week medium-term study (12, 19, 27) (Table 3) .
Recently, the loci responsible for mouse lung tumor susceptibility have been mapped to chromosomes 6, 9, 17, and 19, while those linked to lung tumor resistance have been mapped to chromosome 4, 11, 12, and 18. Known candidate genes for susceptibility or resistance include the K-ras proto-oncogene on chromosome 6, and the p16 tumor supressor gene on chromosome 4. The mouse lung tumor model has been expanded by various researchers including the Chemoprevention Branch of the NCI to include preclinical screening of chemopreventive agents against human lung cancer (28). Furthermore, this model system was also employed to confirm the negative anticarcinogenicity effect of 9-cis retinoic acid, 4-HPR and oltipratz that had been known as promising cancer preventive agents in the NCI recommended model (29) .
ANTICARCINOGENICITY OF TYPES AND AGES OF PANAX GINSENG C.A. MEYER
Using Yun' s model, investigators earlier confirmed the anticarcinogenic effect of 6-yr-old red ginseng extract. In this model, we further investigated the anticarcinogenic effects of fresh or white ginsengs and their derivatives, and the dependency of their anticarcinogenic effects on types and ages of ginseng derivatives. Here, fresh ginseng of 1.5, 3, 4, 5, and 6 yr of age ( Fig. 3 ) was dried at room temperature, finely powdered, and extracted 3 times in a water bath for 8 hr (yield of extract: 45%). White ginseng was also processed in the same way as fresh ginseng after removal of its cortex and fine root (yield of extract: 47%). For preparation of red ginseng, fresh ginseng was steamed, dried, and processed in the same way as fresh ginseng (yield of extract: 51%). Overall, dried fresh ginseng, red ginseng powders or extracts of 1.5, 3, 4, 5, and 6 yr of age, and white ginseng powders or extracts of 3, 4, 5, and 6 yr of age were used. These preparations at 5 mg/mL were orally administered at the weaning, and all the mice were sacrificed at the 9th week. The following results were obtained: 1) the incidence of BPinduced lung adenoma was 41.3%, however, its incidence was reduced in the group treated with the dried fresh ginseng powder. The incidence of lung adenoma induced by BP was reduced to 31.2%, 30.0%, 31.3%, 30.3 and 27.8% (p<0.05) after co-treatment with 1.5-, 3-, 4-, 5-, and 6-yrold dried fresh ginseng powders, respectively. Thus, a statistically significant effect was observed only when treated with 6-yr-old dried fresh ginseng powder. 2) the incidence of BPinduced lung adenoma was 45.0% and its incidence decreased to 41.3%, 38.0%, 31.6% (p<0.05), and 25.3% (p<0.05) after co-treatment with 3-, 4-, 5-, and 6-yr-old white ginseng powders, respectively. Thus, anticarcinogenic effects were observed with 5-and 6-yr-old white ginseng powders.
3) the incidence of lung adenoma was 48.6% in the control group, and its incidence diminished to 37.9%, 41.7%, 31.7% (p<0.05), 28.3% (p<0.05), and 25.4% (p<0.01) after cotreatment with 1.5-, 3-, 4-, 5-, and 6-yr-old red ginseng powders, respectively. Therefore, anticarcinogenic effect was prominent in 4-, 5-, and 6-yr-old red ginseng powders (30) . Simultaneously, each ginseng powders of various types and ages were extracted and these extracts (2.5 mg/mL) were orally administered. All the mice were sacrificed at the 9th week, and the following results were obtained: the incidence of BP induced lung adenoma was 63.9% in the control group for the dried fresh ginseng extract treated group, and its incidence was reduced to 48.3%, 52.5%, 51.8%, 47.5%, and 44.1% (p<0.05) after cotreatment with 1.5-, 3-, 4-, 5-, and 6-yr-old dried fresh ginseng, respectively. Statistical significance was observed only in 6-yr-old dried fresh ginseng extract. The incidence of lung adenoma induced by BP in the control group was 41.3% and were 31.0% 46.0%, 44.0%, and 26.5% (p<0.05) after co-treatment with 3-, 4-, 5-, and 6-yr-old white ginseng extracts, respectively, showing statistically significant effect with 6-yr-old white ginseng extract. In the control group, the incidence of lung adenoma induced by BP was 47.5% and its incidence diminished to 40.7%, 35.0%, 30.1% (p<0.05), 30.0% (p<0.05), and 26.3% (p<0.05) after co-treatment with 1.5-, 3-, 4-, 5-, and 6-yr-old red ginseng extract, respectively, thereby showing the statistically significant anticarcinogenic effects in 4-, 5-, and 6-yr-old red ginseng extracts. From these results, we concluded that significant anticarcinogenic effect was observed in extracts of 6-yr-old dried fresh ginseng, 6-yr-old white ginseng, and 4-, 5-, and 6-yr-old red ginseng. The results also demonstrated that the anticarcinogenicity of ginseng was more prominent in aged or heat treated extracts of fresh Table 3 . Evaluation of anticarcinogenicity using Yun' s 9 week medium-term anticarcinogenicity model (Table 4) .
SUPPORTIVE ANTICARCINOGENIC EFFECTS OF PANAX GINSENG C.A. MEYER IN VARIOUS MODELS IN VITRO AND IN VIVO
In a study on the development of rat liver cancer induced by diethylnitrosamine, only one out of seven rats given red giseng developed a tumor, whereas all of the six control rats succumbed to tumor (33) . Tissue-culture biomass tincture obtained from cultured Panax ginseng cells has a strong inhibitory effect on the development of rat mammary adenocarcinoma induced by methyl-N-nitrosourea administration (34) and experimental uterine cervix and vaginal tumors (35) . Red ginseng extracts had a significant inhibitory effect on skin cancer formation in a two-stage carcinogenesis mouse model: red ginseng extract at 50-400 mg/kg inhibited the development of skin papillomas induced by DMBA and croton oil in mice, decreased in the incidence, prolonged the latent period before tumor occurrence, and reduced tumor number per mouse in a dose-dependent manner (36) . 12-otetradecanoylphorbol-13-acetate (TPA)-induced production of tumor necrosis factor in mouse skin was inhibited by methanol extract of heat-processed neoginseng (37) . Dietary administration of red ginseng powder in the initiation stage of carcinogenesis in the colon of rats suppressed preneoplastic lesions induced by 1,2-dimethylhydrazine; this effect was associated with suppression of cell proliferation (38) .
It should be noted here that Chinese (33, 36) , Russian (34, 35) , Korean (37) and Japanese (38) scientists only recently began to concentrate their effort on the cancer-preventive rather than the general effects of ginseng.
CONSTITUENTS OF PANAX GINSENG C.A. MEYER CULTIVATED IN KOREA
The presence of saponin in ginseng was first reported by identified from the ether soluble fraction of fresh ginseng, and five kinds of methoxypyrazine and eight kinds of alkypyrazine derivatives have been identified from the basic fraction of the ether-soluble extract. Sesquiterpene alcohol, panasinsanols A and B, have also been isolated. Seven kinds of -caboline alkaloid have been isolated from the ether-soluble alkaloidal fraction, and choline has been isolated from the water soluble fraction. Twenty-one kinds of neutral or acidic polysaccharides which make up 50-60% of the ginseng root have been purified and named panaxan A-U consisting of glucose, arabinose, galactose, rhamnose, xylose or uronic acid. Ginseng contains 12 to 15% of nitrogen containing compounds, which are comprised of amino acids, adenosine, and pyroglutamic acid, and Arg-Fru-Glc is formed by amino-carbonyl reaction during the preparation of red ginseng. Other vitamins, inorganic substances, free monosaccharides, and organic acids are also present in ginseng (49) .
ANTICARCINOGENICITY OF VARIOUS GINSENG FRACTIONS
Ginseng has been taken as tonic for a long time in Korea. Therefore, instead of examining its active fractions or components, we focussed our study to confirm whether ginseng has an effective anticarcinogenic agent in humans as it has been shown in rodents for more than 15 yr.
To identify its active fractions, several extracts of red and fresh ginseng were tested for anticarcinogenicity using Yun' s 9 week medium model. For fractionation of red ginseng, powdered red ginseng (2 kg) of 6 yr old Panax ginseng C.A. Meyer cultivated in Korea was extracted with water (2 L×2) at 90℃ and filterd, and one-tenth of the combined filtrates were evaporated to give a "water extract" (104 .4 g). Remaining combined filtrates were successsively extracted with hexane (1 L×3) and water saturated n-BuOH (700 mL×3), and dried to give hexane fraction (1.2 g) and named panaxan A-U consisting of glucose, arabinose, galatose, rhamnose, xylose or uronic acid. The water layer was also evaporated to give water fraction (715.9 g). n-BuOH fraction was chromatographed on silica gel column, and the gel was eluted with CHCl3-MeOH-H2O (10:3:1→7:3:1). Eluates were examined by TLC together with authentic samples, and panaxadiol type saponin (29.2 g) and panaxatriol type saponin (32.8 g) were obtained (50, 51) .
For fractionation of fresh ginseng, fresh ginseng was airdried and powdered. The powdered fresh ginseng (1 kg) was extracted with water (2 L×2) at 90℃ and filtered. Onetenth of the combined filtrates were evaporated to give a water extract (49.2 g), and nine-tenths of the combined filtrates were extracted with ethyl ether (1 L×3) and water saturated n-BuOH (700 mL×3), to give n-BuOH fraction. The combined n-BuOH fraction were dried and evaporated under the reduced pressure to give total saponin (63.6 g).
The powdered fresh ginseng (500 g) was extracted with 70% EtOH (1 L×3) at 80℃ and filtered, and the combined filtrates were then evaporated to give EtOH extract (142.1 g). To obtain polysaccharide fraction from fresh ginseng, the air-dried and powdered fresh ginseng (1 kg) was defatted with 85% EtOH (2 L×3), and the residues were extracted with hot water (1 L×3). The combined extracts were evaporated to appropriate volumes and then dialyzed against running water for 3 days and distilled water for 1 day. After nondialyzate portion was centrifuged to remove insoluble materials, the resulting supernatant was precipitated with 6 volumes of EtOH, and the precipitate was lyophilized to give polysaccharide fraction (13.3 g) (52) .
For the preparation of ginsenoside Rg3 and Rg5 mixture, the ginsenoside Rb1 (10 g) obtained from Korean ginseng (10 g) was hydrolyzed with 50% acetic acid (500 mL) at 70℃ for 3 hr. The reaction mixture, concentrated to appropriate volume, was left at 4℃ for 1 day and filtered. The filtrate was diluted with water (500 mL) and extracted with n-BuOH (250 mL×3). The combined n-BuOH fractions were washed with saturated NaHCO3 solution and evaporated under the reduced pressure. The residue was chromatographed on silica gel column, using CHCl3-MeOH-H2O (9:3:1) as solvent, to obtain ginsenoside Rg3 and Rg5 mixture. Ginsenoside Rg3 and Rg5 mixtures were subjected to HPLC (Waters 244, CLC-ODS, RI dectector), using acetonitril-water (60:40) as mobile phase, to analyze the ratio of ginsenoside Rg3 to Rg5 (2.6 g) (45, 50) .
The ginseng fractions were administered to newborn mice after weaning for 6 weeks: Red ginseng water extract (2 mg/ mL drinking water), hexane fraction (21.9 g/mL), ether fraction (42.3 g/mL), panaxadiol type saponin (67.7 g/mL), panaxatriol type saponin (56.6 g/mL) or water extract (811.4 g/mL) in experiment 1; 70% ethanol extract of fresh ginseng (4.72 mg/mL), total saponin of fresh ginseng (0.44 mg/mL) and polysaccharide of fresh ginseng (1.32 mg/mL) in experiment 2; ginsenoside Rg3+Rg5 (7:3 ratio, 80 g/mL) in experiment 3. All mice were sacrificed at the 9th week after birth.
Lung adenoma incidence was 46.8% in mice treated with 0.5mg of BP. However, when treated together with red ginseng, the incidence significantly reduced to 27.5% (inhibition rate 36.8%). Panaxadiol type saponin, panaxatriol type saponin, hexane fraction and water fraction showed 42.3%, 41.3%, 40.0% and 41.3% incidence, respectively, with no significant reduction observed in experiment 1 ( Table 5) .
The next step was to compare anticarcinogenicity of 6 yr fresh ginseng fractions of 70% ethanol extract, water extract, total saponin and polysaccharide. Lung adenoma incidence was 58.3% in 0.5 mg of BP alone treated mice. The treatment of ethanol extract and total saponin together with BP reduced lung tumor incidence significantly to 44.1% (inhibition rate 25.7%) and 43.3% (inhibition rate 24.4%), respectively, however the incidence of polysaccharide treatment was 50.0%, with no significant reduction being observed in experiment 2 (Table 6) . Experiment 3 was to examine which components of red ginseng were responsible for anticarcinogenicity. For the experiment, Rg3 and Rg5 mixtures were selected, because they are present in large amounts in red ginseng and their semi-syntheses are possible. Lung adenoma incidence was 60.0% in 0.5 mg of BP alone treated mice, however, the treatment of Rg3+Rg5 mixture with BP significantly reduced the incidence to 45.0% (inhibition rate 25.0%). The results showed that Rg3+Rg5 had anticarcinogenic effect in Yun' s model (50) ( Table 7) .
Since red ginseng showed the most effective anticarcinogenicity, semi-synthesized ginsenoside Rg3 and Rg5 mixtures were selected for experiment. The results showed significant inhibition of lung adenoma in the Yun' s model, indicating that ginsenoside Rg3 and Rg5, alone or in combination, would be active anticarcinogenic components.
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T. Table 6 . Effects of ethanol extract, water extract, total saponin and polysaccharide isolated from fresh ginseng on the incidence of benzo(a)pyrene induced lung tumor in mice, using Yun' s 9 week medium-term anticarcinogenicity test model 
IDENTIFICATION OF ACTIVE ANTICARCINO-GENIC COMPONENTS IN RED GINSENG
Fresh Panax ginseng C.A. Meyer cultivated in Korea (Korean red ginseng) was reported to be ineffective as anticarcinogenic or cancer preventive agent both in experimental animal model and in human case-control and cohort study. However, when treated with heat, the fresh or white ginseng and red ginseng were highly effective in cancer prevention. Consequently, we purified four compounds, 20(S)-ginsenoside Rhl (Rhl) (54), 20(S)-ginsenoside Rh2 (Rh2) (55), 20(S)-gisenoside Rg3 (Rg3) and ginsenoside Rg5 (55) from Korean red ginseng and tested them by Yun' s model. Ginsenoside Rg5 was isolated as previously described (45), and Rg3 and Rh2 were by usual procedure from Korean red ginseng (51, 55) . In brief, a mixture of 20(R)-and 20(S)-ginsenoside Rg3 was obtained under mild acidic hydrolysis from protopanaxadiol saponins, ginsenoside Rb1, Rb2, Rc and Rd. The product was acetylated to give peracetates, which were further converted into 20(S)-ginsenoside Rg3, 20(R)-ginsenoside Rg3, 20(S)-ginsenoside Rh2 and 20(R)-ginsenoside Rh2 by direct alkaline treatment, while Rh1 was prepared from ginsenoside Re by similar procedure (55) . All ginsenosides obtained were identified by physicochemical and spectral analysis (IR, MASS, 1 H, 13 C-NMR). Thereafter N:GP(S) mice were subcutaneously injected once with 0.02 mL of BP suspension (0.5 mg, in l% aqueous gelatin), and the following ginsenosides were administered in drinking water (80 g/mL) for 6 weeks; ginsenosides Rh1, Rh2, Rg3 and Rg5 (Fig. 4) . Two control groups consisted of normal animals (no ginseng was given) and red-ginseng administered (but no BP-treated). Red ginseng extract (2 mg/mL of drinking water) was given immediately after weaning. Drinking water was changed every other day and diet was prepared every other week. At the 9th week after birth, adenomas of the lung were counted. There was no lung tumor observed in both normal control mice (no BP administered) and mice given with ginsenoside Rh1, Rh2, Rg3 or Rg5 alone. However, 60% of lung tumor incidence was found in the group given once with 0.5 mg of BP. On the other hand, when given with 2 mg of red ginseng extract for 6 week after benzo(a)pyrene pretreatment, 43.3% of incidence was observed (27.8% decrease), which was statistically significant. The incidence of lung adenoma showed 51.7% in mice treated with ginsenoside Rh1, indicating no significant effect of Rh1 on the BPinduced lung tumor. The incidence of lung tumor in mice treated with ginsenoside Rh2 and BP showed 48.3% (19.5% decrease). Although it was not statistically significant, we considered it to represent "tendency of decrease"in the incidence.
When given with 80 g/mL concentration for 6 weeks after BP administration, Rg3 showed statistically significant decrease (22.2%) in lung tumor incidence (46.7%; p<0.05), whereas Rg5 and BP had biologically significant incidence (45.0% and 25.0% decrease) (p<0.05) ( Table 8) .
Using Yun' s model, the above results, therefore, demonstrated that, among the four ginsenosides purified from red ginseng, Rg3 and Rg5 revealed significant reduction of lung tumor incidence, while Rh2 had a tendency of decreasing the incidence, indicating that ginseng is an active cancer chemopreventive agent (53) . Table 7 . Effects of ginsenoside Rg3+Rg5 mixture on the incidence of benzo(a)pyrene inducecd lung tumor in mice, using Yun' s 9 week medium-term anticarcinogenicity test model (60); and immunomodulating activity of Rg1 in mice (61, 62) . The red ginseng was found to activate natural killer cells in mice with lung adenoma induced by urethane and benzo(a)pyrene (63) . The polysaccharide revealed anticomplementary activity (64, 65) , reticuloendothelial system-potentiating activity, alkaline phosphatase-inducing activity (66) , and cytoprotective activity (67, 68) . Lately, various polyacetylenes extracted from ginseng (69, 70) are known to have cytotoxic activity (71) .
Ginsenoside Rh1 and Rh2 have recently been reported to cause differentiation of F9 teratocarcinoma cells, and it has been suggested that the effects of ginsenosides might have been exerted via binding with a glucocorticoid receptor or its analogous nuclear receptor (60) . In nude mice bearing HRA cell tumors, oral administration of Rh2 resulted in a significant retardation of tumor growth, consequently markedly prolonging survival time (58) . The systemic as well as oral multiple administrations of ginsenoside Rg3 inhibited lung metastasis produced by Bl6-BL6 melanoma and Colon 26-M3.l carcinoma cells in mice. This antimetastatic effect was thought to be associated with the inhibition of the invasion and adhesion by tumor cells as well as suppression of tumor-induced angiogenesis (72) (73) (74) (75) (76) (77) . These results dealt mostly with induction of tumor cell differentiation, inhibition of tumor growths, prolongation of animal survival times or inhibition of metastasis. Generally, characteristics of the anticancer effect of ginseng may be summarized as follows: 1) it is observed only in slow-growing tumors such as Ehrlich and sarcoma 180 ascites tumours in vivo, 2) it is not observed in rapidly growing tumors such as L1210, P388 ascites tumors and Walker carcinosarcoma, and 3) there is no doseresponse relationship and no cumulative effect (78) (79) (80) (81) (82) .
Our strategy now is to switch from therapeutic approaches to chemoprevention of cancer by identifying effective natural products. Anticarcinogenic effects of Korean red ginseng was earlier observed in l980 by long-term (6, 8) or medium term model (Yun' s model) (9-12) with mouse lung tumor. We observed that anticarcinogenicity of ginseng was dependent on the type and age of the ginseng (30, 31) . In two attempts with human case-control studies (83, 84) and a cohort study (85) to evaluate the cancer preventive effect, however, fresh ginseng was found to be ineffective to decrease the relative risk (RR). On the other hand, when treated with heat, fresh ginseng, white ginseng and red ginseng were significantly effective in the decrease of RR, similar to the results obtained from animal experiments. This result suggested the generation of active cancer chemopreventive compounds of Korean ginseng by heat-treatment.
At present, 35 ginsenosides have been identified in gin- seng, and l2 ginsenosides were found in red ginseng (86) . We prepared four ginsenosides from Korean red ginseng and tested their cancer chemopreventive effect using Yun' s model. This model has been successfully employed to confirm anticarcinogenicity effect of ginseng on lung tumor incidence induced by benzo(a)pyrene in mice. Mouse lung tumor model has been highly recommended for preclinical as well as clinical test models (28, 29) , because this model showed no anticarcinogenicity with not only -carotene and 13-cis retinoic acid (10) (11) (12) 19) , but also genetic alteration in mouse lung tumor which was similarly to that of human lung cancer cells. When taken, 4 yr-old fresh or white ginseng did not show any anticarcinogenicity in animal model (30, 31) , and an epidemiological study also revealed no statistically significant reduction of the relative risk in human (83) (84) (85) . When heated, however, these ginsengs were highly effective as anticarcinogenic agents and these results were confirmed by others (33) (34) (35) (36) (37) (38) . Red ginseng extract in a two-stage carcinogenesis mouse model had a significant inhibitory effect on skin cancer formation. At 50-400 mg/kg, red ginseng extract inhibited DMBA/croton oil-induced skin papillomas in mice, decreased the incidence, prolonged the latent period before tumor occurrence, and reduced tumor number per mouse in a dose-dependent manner (36) . Recently, it has been shown that dietary administration of red ginseng powder in the initiation stage of carcinogenesis was found to suppress 1, 2-dimethylhydrazine (DMH) induced preneoplastic lesions in the colon of rats, and that this was associated with suppression of cell proliferation (38) .
This fact led to search biologically active components in ginseng, and they so far identified 35 ginsenosides in general and l2 in red ginseng (86) .
Some of the ginsenosides are present in red ginseng in such a minute quantity, so that it is extremely difficult to obtain the amount enough for in vivo assay. Nevertheless, we succeeded to purify and identify four ginsenosides, including ginsenoside Rhl, Rh2, Rg3 and Rg5. Among the four ginsenosides, Rg3 and Rg5 showed significant reduction of lung tumor incidence and Rh2 had a tendency of decreasing the incidence. These results strongly indicate that the anticarcinogenicity or human cancer preventive effect of ginseng is due to ginsenoside Rg3, Rg5 and Rh2.
There has been no report yet on the preventive effect of ginsenoside Rg3, Rg5 and Rh2 on chemically induced cancer or spontaneous murine cancer in vivo. Ginsenoside Rg5 was isolated from methanol extract of Korean red ginseng in 1996 (45), however, there is no report yet on biological activity of the compound.
Although the mechanism of how these three minor ginsenosides exhibit the anticarcinogenic effect is not known, it is highly likely that Rg3, Rg5 and Rh2 in red ginseng prevent cancer either singularly or synergistically, and it is quite tempting to suggest that the ginsenosides may target one of the 5 steps of either Vogelstein' s multi-stage carcinogenesis or inactivation of suppressor genes (87).
In conclusion, epidemiological studies including case-control studies (83, 84) and population based cohort study (85) proved heat-treated red ginseng to be effective non-organ specific cancer preventive (19, 85, 86, 88, 89) . In order to further confirm these ginsenosides as non-organ specific cancer preventive, it is of absolute necessity to chemically synthesize large amounts of the materials for clinical testing as well.
